Document Detail


Adherence and persistence to a regimen of basal insulin in a pre-filled pen compared to vial/syringe in insulin-na?ve patients with type 2 diabetes.
MedLine Citation:
PMID:  21740289     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Objective: This study was conducted to compare adherence and persistence of patients initiating basal insulin therapy with Levemir FlexPen versus those initiating basal insulin therapy with NPH via vial and syringe. Materials and methods: Data were gathered from a large US retrospective claims database, and included patients with type 2 diabetes that initiated basal insulin therapy with either Levemir FlexPen or NPH in vials. Patients were defined as adherent to therapy if they had a medication possession ratio (MPR) of ?80% in the 12-month follow-up period and were defined as persistent with therapy if they had no gaps in insulin therapy in the follow-up period. Results: After controlling for confounders using logistic regression, patients initiating therapy with Levemir FlexPen had 39% higher adjusted odds of achieving an MPR ?80% versus patients initiating therapy with NPH vial (OR 1.39; 95% CI: 1.04?1.85). Analysis of persistence using a Cox proportional hazards model indicated that patients initiating Levemir FlexPen had a 38% lower hazard of discontinuation compared to NPH vial (HR 0.62, 95% CI: 0.55?0.70). Limitations: Claims-based studies are limited to the extent that they accurately capture medical and pharmacy use. Also, relying on claims-based data limits the generalizability of the findings to similar populations and treatments. Conclusions: These results suggest that persistence and adherence with insulin may be improved for patients initiating basal insulin therapy with Levemir FlexPen versus NPH vial.
Authors:
Erin Buysman; Christopher Conner; Mark Aagren; Jonathan Bouchard; Fang Liu
Related Documents :
1323279 - Evidence for the lack of spare high-affinity insulin receptors in skeletal muscle.
21106709 - Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar ve...
15523589 - Increase of pten gene expression in insulin resistance.
3050369 - Insulin inhibits protein degradation in skeletal muscles of eviscerated fasted rats.
17869249 - The ppardelta agonist, gw501516, promotes fatty acid oxidation but has no direct effect...
2240209 - Insulin- and thyroid hormone-independent adaptation of myofibrillar proteolysis to gluc...
7657039 - Both subcutaneously and intravenously administered glucagon-like peptide i are rapidly ...
21204999 - Impact of streptozotocin-induced diabetes on functional responses of dendritic cells an...
16831449 - Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, a...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-7-11
Journal Detail:
Title:  Current medical research and opinion     Volume:  -     ISSN:  1473-4877     ISO Abbreviation:  -     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-7-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0351014     Medline TA:  Curr Med Res Opin     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
OptumInsight , 12125 Technology Drive, Eden Prairie, MN 55344 , USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Combination antiresorptive and osteoanabolic therapy for osteoporosis: We are not there yet.
Next Document:  Cost-effectiveness of risk stratification for preventing type 2 diabetes using a multi-marker diabet...